| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adherence to BCR-ABL Inhibitors: Issues for CML Therapy
|
Jabbour, Elias
|
|
2012
|
12 |
4 |
p. 223-229
7 p.
|
artikel
|
| 2 |
Clinical Binding Properties, Internalization Kinetics, and Clinicopathologic Activity of Brentuximab Vedotin: An Antibody-Drug Conjugate for CD30-Positive Lymphoid Neoplasms
|
Fromm, Jonathan R.
|
|
2012
|
12 |
4 |
p. 280-283
4 p.
|
artikel
|
| 3 |
Clinical Cytogenetics in Pediatric Acute Leukemia: An Update
|
Braoudaki, Maria
|
|
2012
|
12 |
4 |
p. 230-237
8 p.
|
artikel
|
| 4 |
Cutaneous Lesion Induced by a Subcutaneous Administration of Bortezomib
|
Obeid, Karam M.
|
|
2012
|
12 |
4 |
p. 284-286
3 p.
|
artikel
|
| 5 |
Detection of CD34, TdT, CD56, CD2, CD4, and CD14 by Flow Cytometry Is Associated With NPM1 and FLT3 Mutation Status in Cytogenetically Normal Acute Myeloid Leukemia
|
Dalal, Bakul I.
|
|
2012
|
12 |
4 |
p. 274-279
6 p.
|
artikel
|
| 6 |
Does an Elevated Serum Vitamin B12 Level Mask Actual Vitamin B12 Deficiency in Myeloproliferative Disorders?
|
Gauchan, Dron
|
|
2012
|
12 |
4 |
p. 269-273
5 p.
|
artikel
|
| 7 |
Editorial Board
|
|
|
2012
|
12 |
4 |
p. A6-
1 p.
|
artikel
|
| 8 |
Hairy Cell Leukemia: Allogeneic Transplantation Could be an Optimal Option in Selected Patients
|
Zinzani, Pier Luigi
|
|
2012
|
12 |
4 |
p. 287-289
3 p.
|
artikel
|
| 9 |
Mutational Status and Gene Repertoire of IGHV-IGHD-IGHJ Rearrangements in Serbian Patients With Chronic Lymphocytic Leukemia
|
Karan-Djurasevic, Teodora
|
|
2012
|
12 |
4 |
p. 252-260
9 p.
|
artikel
|
| 10 |
Pralatrexate Is an Effective Treatment for Relapsed or Refractory Transformed Mycosis Fungoides: A Subgroup Efficacy Analysis From the PROPEL Study
|
Foss, Francine
|
|
2012
|
12 |
4 |
p. 238-243
6 p.
|
artikel
|
| 11 |
Table of Contents
|
|
|
2012
|
12 |
4 |
p. A7-A8
nvt p.
|
artikel
|
| 12 |
The Effects of Increased Expression of DLK1 Gene on the Pathogenesis of Myelodysplastic Syndromes
|
Ma, Xiaotang
|
|
2012
|
12 |
4 |
p. 261-268
8 p.
|
artikel
|
| 13 |
Twice-Daily Fludarabine and Cytarabine Combination With or Without Gentuzumab Ozogamicin is Effective in Patients With Relapsed/Refractory Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, and Blast- Phase Chronic Myeloid Leukemia
|
Jabbour, Elias
|
|
2012
|
12 |
4 |
p. 244-251
8 p.
|
artikel
|
Tijdschrift beschrijving